Adalimumab Market Growth, Trend, Price and Forecast to 2024 Adalimumab Market - Global Industry Analysis, Size | Page 2

Adalimumab, however, is an expensive drug on account of its biologic nature. It
costs somewhere between US$2000 and US$3000 per month. This is one factor that
is serving to counter the growth in its market.
The global adalimumab market can be segmented on the basis of the type of
disease into rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn’s disease, and
ulcerative colitis. At present, the rheumatoid arthritis segment grosses maximum
revenue and going forward too will outshine all other segments in terms of growth.
Global Adalimumab Market: Geographical Segmentation
Geographically, the key segments of the global adalimumab market are North
America, Western Europe, Latin America, Asia Pacific, Eastern Europe, and the
Middle East and Africa. Among them, North America and Europe are key markets.
This is because of a well-structured regulatory framework, proper reimbursement
coverage, and superior healthcare infrastructure, particularly in the countries of
Canada, the U.S., the U.K., and Germany. The sizeable proportion of arthritis cases
owing to a sedentary lifestyle has also led to the growth in the market in the two
continents. Asia Pacific, on the other hand, holds out a strong promise of growth in
the near future on account of a cluster of fast-expanding developing nations in the
region.
Global Adalimumab Market: Competitive Landscape
To assess the competition prevailing in the global market for adalimumab, the report
profiles major players such as Pfizer, Amgen, Novartis AG, Boehringer Ingelheim
GmbH, Mylan N.V., and AbbVie. At present, the most prominent player in the market
is Abbott Laboratories. However, after the split of Abbott laboratories into two
companies in 2013, Humira is now the product of AbbVie.
Get accurate market forecast and analysis on the Adalimumab market.
Request a sample to stay abreast on the key trends impacting this market.
http://www.transparencymarketresearch.com/sample/sample.php?
flag=B&rep_id=7292
Major regions analyzed under this research report are:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium,
Netherlands, and Luxembourg)